Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06241482 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Eligibility criteria shortened, about 1 wordv6 See this version in full on ClinicalTrials.gov ↗
  2. Notable Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 1, 2024 to Oct 15, 2024 · Site details revisedv5 Show 2 more changesShow less
    • Start date changed from estimate of Oct 1, 2024 to Oct 15, 2024
    • Site details revised
  3. Notable Primary and study completion dates: Feb 28, 2026 to Apr 30, 2027 Start date: May 1, 2024 to Oct 1, 2024 · Collaborators expanded, about 7 wordsv4 Show 2 more changesShow less
    • Start date: May 1, 2024 to Oct 1, 2024
    • Collaborators expanded, about 7 words

    See this version in full on ClinicalTrials.gov ↗

  4. Notable Start date: Mar 1, 2024 to May 1, 2024v3
  5. Minor Re-verified, no change to tracked fieldsv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Enhanced recovery after surgery (ERAS) is a strategy of perioperative management aimed to accelerate the rehabilitation of patients through various optimized perioperative managements as well as ongoing adherence to a patient-focused, multidisciplinary, and multimodal approach. Alleviating the injury and stress caused by surgery or disease is the core principle of ERAS, which has been shown to reduce complication rates after surgery, promote patient recovery, decrease hospital length of stay and reduce costs. ERAS has been widely applied in many surgical perioperative fields, and it has achieved remarkable effects. However, there are few applications of ERAS in neurosurgery, especially in clinical trials of neurocritical care patients. Therefore, the investigators attempt to conduct the study of ERAS in neurosurgical intensive patients using a series of optimized perioperative managements that have been verified to be effective by evidence-based medicine, and to evaluate the safety and effectiveness of ERAS in neurocritical care. The aim of this study is to explore the most suitable ERAS protocols to accelerate the postoperative rehabilitation process of neurocritical care patients, and to provide more evidence-based medicine for the effectiveness and safety of ERAS in neurosurgery.
Trial Details
NCT Number NCT06241482
Lead Sponsor Shanghai 6th People's Hospital
Collaborators: Shanghai Jiao Tong University School of Medicine
Conditions Neurocritical Care, Traumatic Brain Injury, Cerebrovascular Disease, Moderate or Severe Coma
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov